S&P 500   3,311.72 (-0.30%)
DOW   29,044.88 (-0.48%)
QQQ   223.79 (-0.04%)
AAPL   318.05 (+0.11%)
FB   219.85 (-0.66%)
MSFT   166.09 (+0.24%)
NVDA   251.60 (+0.62%)
BABA   217.89 (-2.01%)
MU   59.48 (+0.52%)
GE   11.71 (+2.99%)
TSLA   566.11 (-0.61%)
AMD   51.23 (-0.39%)
T   38.57 (-1.23%)
NFLX   342.37 (+5.02%)
BAC   33.95 (-1.19%)
DIS   141.57 (-1.69%)
GILD   63.14 (-0.46%)
S&P 500   3,311.72 (-0.30%)
DOW   29,044.88 (-0.48%)
QQQ   223.79 (-0.04%)
AAPL   318.05 (+0.11%)
FB   219.85 (-0.66%)
MSFT   166.09 (+0.24%)
NVDA   251.60 (+0.62%)
BABA   217.89 (-2.01%)
MU   59.48 (+0.52%)
GE   11.71 (+2.99%)
TSLA   566.11 (-0.61%)
AMD   51.23 (-0.39%)
T   38.57 (-1.23%)
NFLX   342.37 (+5.02%)
BAC   33.95 (-1.19%)
DIS   141.57 (-1.69%)
GILD   63.14 (-0.46%)
S&P 500   3,311.72 (-0.30%)
DOW   29,044.88 (-0.48%)
QQQ   223.79 (-0.04%)
AAPL   318.05 (+0.11%)
FB   219.85 (-0.66%)
MSFT   166.09 (+0.24%)
NVDA   251.60 (+0.62%)
BABA   217.89 (-2.01%)
MU   59.48 (+0.52%)
GE   11.71 (+2.99%)
TSLA   566.11 (-0.61%)
AMD   51.23 (-0.39%)
T   38.57 (-1.23%)
NFLX   342.37 (+5.02%)
BAC   33.95 (-1.19%)
DIS   141.57 (-1.69%)
GILD   63.14 (-0.46%)
S&P 500   3,311.72 (-0.30%)
DOW   29,044.88 (-0.48%)
QQQ   223.79 (-0.04%)
AAPL   318.05 (+0.11%)
FB   219.85 (-0.66%)
MSFT   166.09 (+0.24%)
NVDA   251.60 (+0.62%)
BABA   217.89 (-2.01%)
MU   59.48 (+0.52%)
GE   11.71 (+2.99%)
TSLA   566.11 (-0.61%)
AMD   51.23 (-0.39%)
T   38.57 (-1.23%)
NFLX   342.37 (+5.02%)
BAC   33.95 (-1.19%)
DIS   141.57 (-1.69%)
GILD   63.14 (-0.46%)
Log in
(Ad)
CNN calls 5G "the lifeblood of the new economy." If you don't invest now, you'll regret it later.

NASDAQ:FLGT - Fulgent Genetics Stock Price, Forecast & News

$13.86
-0.08 (-0.57 %)
(As of 01/23/2020 12:43 PM ET)
Today's Range
$13.79
Now: $13.86
$13.96
50-Day Range
$11.43
MA: $13.27
$15.12
52-Week Range
$3.57
Now: $13.86
$16.50
Volume1,218 shs
Average Volume241,899 shs
Market Capitalization$259.32 million
P/E RatioN/A
Dividend YieldN/A
Beta1.05
Fulgent Genetics, Inc, together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves hospitals and medical institutions. Read More…

Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:FLGT
CUSIPN/A
Phone626-350-0537

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$21.36 million
Book Value$2.83 per share

Profitability

Net Income$-5,610,000.00

Miscellaneous

Employees123
Market Cap$259.32 million
Next Earnings Date2/27/2020 (Estimated)
OptionableNot Optionable

Receive FLGT News and Ratings via Email

Sign-up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter.


(Ad)

Located just 25 miles from Cleveland... is a supergreenhouse unlike anything we've ever seen. Listed at over 1.4 million sq ft, (the size of 9 full-sized Costco warehouses), this marijuana grow house is capable of producing over 341,000 pounds of weed/year! And very soon it will come online and could turn a tiny 60-cent pot company into the dominator in the white-hot weed market.

Fulgent Genetics (NASDAQ:FLGT) Frequently Asked Questions

What is Fulgent Genetics' stock symbol?

Fulgent Genetics trades on the NASDAQ under the ticker symbol "FLGT."

How were Fulgent Genetics' earnings last quarter?

Fulgent Genetics Inc (NASDAQ:FLGT) issued its quarterly earnings data on Monday, November, 4th. The company reported $0.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.01 by $0.08. The business earned $10.35 million during the quarter, compared to analyst estimates of $8.48 million. Fulgent Genetics had a negative return on equity of 0.16% and a negative net margin of 3.52%. View Fulgent Genetics' Earnings History.

When is Fulgent Genetics' next earnings date?

Fulgent Genetics is scheduled to release their next quarterly earnings announcement on Thursday, February 27th 2020. View Earnings Estimates for Fulgent Genetics.

What price target have analysts set for FLGT?

2 analysts have issued 12 month price objectives for Fulgent Genetics' stock. Their forecasts range from $12.30 to $12.30. On average, they expect Fulgent Genetics' share price to reach $12.30 in the next twelve months. This suggests that the stock has a possible downside of 11.3%. View Analyst Price Targets for Fulgent Genetics.

What is the consensus analysts' recommendation for Fulgent Genetics?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fulgent Genetics in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Fulgent Genetics.

Has Fulgent Genetics been receiving favorable news coverage?

News stories about FLGT stock have been trending extremely negative this week, InfoTrie Sentiment reports. The research firm scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Fulgent Genetics earned a news sentiment score of -4.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Fulgent Genetics.

Are investors shorting Fulgent Genetics?

Fulgent Genetics saw a increase in short interest in the month of December. As of December 31st, there was short interest totalling 289,700 shares, an increase of 33.2% from the December 15th total of 217,500 shares. Based on an average trading volume of 311,500 shares, the short-interest ratio is currently 0.9 days. Approximately 3.7% of the shares of the stock are sold short. View Fulgent Genetics' Current Options Chain.

Who are some of Fulgent Genetics' key competitors?

What other stocks do shareholders of Fulgent Genetics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fulgent Genetics investors own include Crispr Therapeutics (CRSP), Baidu (BIDU), Baozun (BZUN), NVIDIA (NVDA), Alibaba Group (BABA), Zynerba Pharmaceuticals (ZYNE), Canopy Growth (CGC), Innovative Industrial Properties (IIPR), InVitae (NVTA) and TENCENT HOLDING/ADR (TCEHY).

Who are Fulgent Genetics' key executives?

Fulgent Genetics' management team includes the folowing people:
  • Mr. Ming Hsieh, Chairman, CEO & Pres (Age 63)
  • Mr. Paul Kim, Chief Financial Officer (Age 52)
  • Dr. Han Lin Gao, Chief Scientific Officer & Lab Director (Age 52)

When did Fulgent Genetics IPO?

(FLGT) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,600,000 shares at $12.00-$14.00 per share. Credit Suisse and Piper Jaffray served as the underwriters for the IPO and Raymond James and BTIG were co-managers.

Who are Fulgent Genetics' major shareholders?

Fulgent Genetics' stock is owned by a number of of retail and institutional investors. Top institutional investors include Raymond James Trust N.A. (2.24%), Wedge Capital Management L L P NC (0.46%) and Calamos Advisors LLC (0.27%). Company insiders that own Fulgent Genetics stock include Ming Hsieh and Paul Kim. View Institutional Ownership Trends for Fulgent Genetics.

Which major investors are selling Fulgent Genetics stock?

FLGT stock was sold by a variety of institutional investors in the last quarter, including Raymond James Trust N.A.. View Insider Buying and Selling for Fulgent Genetics.

Which major investors are buying Fulgent Genetics stock?

FLGT stock was purchased by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC and Calamos Advisors LLC. View Insider Buying and Selling for Fulgent Genetics.

How do I buy shares of Fulgent Genetics?

Shares of FLGT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Fulgent Genetics' stock price today?

One share of FLGT stock can currently be purchased for approximately $13.86.

How big of a company is Fulgent Genetics?

Fulgent Genetics has a market capitalization of $259.32 million and generates $21.36 million in revenue each year. The company earns $-5,610,000.00 in net income (profit) each year or ($0.19) on an earnings per share basis. Fulgent Genetics employs 123 workers across the globe.View Additional Information About Fulgent Genetics.

What is Fulgent Genetics' official website?

The official website for Fulgent Genetics is http://www.fulgentgenetics.com/.

How can I contact Fulgent Genetics?

Fulgent Genetics' mailing address is 4978 SANTA ANITA AVENUE SUITE 205, TEMPLE CITY CA, 91780. The company can be reached via phone at 626-350-0537 or via email at [email protected]


MarketBeat Community Rating for Fulgent Genetics (NASDAQ FLGT)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  183 (Vote Outperform)
Underperform Votes:  218 (Vote Underperform)
Total Votes:  401
MarketBeat's community ratings are surveys of what our community members think about Fulgent Genetics and other stocks. Vote "Outperform" if you believe FLGT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FLGT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel